Zhu Jiaqi, Lai Yunqiang, Cheng Mengqi, Dash Radha Charan, Guo Shuangshuang, Guo Jintong, Su Yue, Wolek Andrew, Issacs Brianna, Liu Zhenming, Li Qi, Mishra Neha, Garmendia Antonio, Hadden M Kyle, Tian X Cindy, He Xin, Tang Young
Department of Animal Science, Institute for Systems Genomics, University of Connecticut, Storrs, Connecticut, USA.
Shaanxi Centre of Stem Cells Engineering & Technology, Key Laboratory of Livestock Biology, Engineering Research Center of Efficient New Vaccines for Animals, Ministry of Education and Universities of Shaanxi Province, College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China.
J Virol. 2025 Feb 25;99(2):e0203424. doi: 10.1128/jvi.02034-24. Epub 2024 Dec 31.
Porcine reproductive and respiratory syndrome (PRRS) remains a major threat to animal health and causes substantial economic losses worldwide. The nonstructural protein 11 (NSP11) of the causative agent, PRRS virus (PRRSV), contains a highly conserved nidoviral uridylate-specific endoribonuclease (NendoU) domain essential for viral replication and immune evasion. Targeting NSP11 offers a novel approach to antiviral intervention. Through virtual screening followed by a fluorescence resonance energy transfer assay , we identified A8-A2 as a promising candidate that effectively inhibits NendoU activity. Molecular docking and mutational analysis revealed that A8-A2 and its analogs target the key catalytic residues His144 and Thr217 of NSP11, located within the NendoU enzyme activity loop and pocket region, respectively. A8-A2 demonstrated dose-dependent inhibition of PRRSV replication in porcine alveolar macrophages. Notably, the NendoU is conserved across PRRSV strains and other Nidoviruses, and A8-A2 exhibited antiviral activity against both type I and type II PRRSV strains, as well as the infectious bronchitis virus, a coronavirus in the order . Further investigations revealed that A8-A2 impedes viral replication early in infection and reverses NSP11-mediated suppression of Poly(I:C)-induced interferon production. However, this effect occurs independently of mRNA splicing inhibition. These findings indicate that A8-A2 could act as an effective antiviral agent against infections caused by diverse PRRSV strains and may serve as a broad-spectrum agent for other Nidoviruses.
Porcine reproductive and respiratory syndrome virus (PRRSV) causes significant economic losses in the pig industry, and vaccination is the principal method to prevent this viral infection currently. However, vaccination often fails to provide protection against heterologous strains, highlighting the need for alternative strategies for broad protection. The nidoviral uridylate-specific endoribonuclease (NendoU) domain plays a crucial role in viral replication and evasion of host immune responses. In this study, we identified a group of new compounds with similar chemical structures that could interfere with NendoU enzyme activity. Among these compounds, A8-A2 significantly inhibited PRRSV replication in host cells with minimal cytotoxicity. Our findings provide a new direction for developing potent antiviral compounds that can offer broad protection against different PRRSV strains, thereby mitigating their impact on pig health and benefiting the husbandry industry.
猪繁殖与呼吸综合征(PRRS)仍然是对动物健康的主要威胁,并在全球范围内造成巨大经济损失。致病因子猪繁殖与呼吸综合征病毒(PRRSV)的非结构蛋白11(NSP11)包含一个高度保守的巢式病毒尿苷酸特异性内切核糖核酸酶(NendoU)结构域,这对于病毒复制和免疫逃逸至关重要。靶向NSP11提供了一种新的抗病毒干预方法。通过虚拟筛选,随后进行荧光共振能量转移测定,我们确定A8 - A2是一种有前景的候选物,可有效抑制NendoU活性。分子对接和突变分析表明,A8 - A2及其类似物靶向NSP11的关键催化残基His144和Thr217,它们分别位于NendoU酶活性环和口袋区域内。A8 - A2在猪肺泡巨噬细胞中表现出对PRRSV复制的剂量依赖性抑制。值得注意的是,NendoU在PRRSV毒株和其他巢式病毒中是保守的,并且A8 - A2对I型和II型PRRSV毒株以及传染性支气管炎病毒(一种该目下的冠状病毒)均表现出抗病毒活性。进一步研究表明,A8 - A2在感染早期阻碍病毒复制,并逆转NSP11介导的对聚肌苷酸 - 聚胞苷酸(Poly(I:C))诱导的干扰素产生的抑制。然而,这种作用独立于mRNA剪接抑制发生。这些发现表明,A8 - A2可以作为一种有效的抗病毒剂,对抗由多种PRRSV毒株引起的感染,并且可能作为针对其他巢式病毒的广谱药物。
猪繁殖与呼吸综合征病毒(PRRSV)在养猪业中造成重大经济损失,并且疫苗接种是目前预防这种病毒感染的主要方法。然而,疫苗接种往往无法提供针对异源毒株的保护,这凸显了需要替代策略以提供广泛保护。巢式病毒尿苷酸特异性内切核糖核酸酶(NendoU)结构域在病毒复制和逃避宿主免疫反应中起关键作用。在这项研究中,我们鉴定出一组具有相似化学结构的新化合物,它们可以干扰NendoU酶活性。在这些化合物中,A8 - A2在宿主细胞中显著抑制PRRSV复制,且细胞毒性最小。我们的发现为开发能够针对不同PRRSV毒株提供广泛保护的有效抗病毒化合物提供了新方向,从而减轻它们对猪健康的影响并使畜牧业受益。